よむ、つかう、まなぶ。
04資料2-1_森野委員提出資料（おたふくかぜワクチンファクトシート第２版） (39 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_73851.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第34回 6／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
California, 2011. MMWR Morb Mortal Wkly Rep 2012; 61(48): 986–9.
38.
Hassan J, Kelly J, De Gascun C. Presence of low mumps-specific IgG in oral fluids is
associated with high mumps viral loads. J Clin Virol 2020; 129: 104517.
39.
Okafuji T, Yoshida N, Fujino M, et al. Rapid diagnostic method for detection of mumps virus
genome by loop-mediated isothermal amplification. J Clin Microbiol 2005; 43(4): 1625–31.
40.
Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and
its complications in Germany, 2005-2009. J Infect 2015; 70(2): 178–86.
41.
World Health Organization. Mumps virus vaccines: WHO position paper, March 2024.
Weekly Epidemiological Record 2024; 99(11): 115–33.
42.
Tarumi T, Sawada K, Koizumi K, et al. A pilot study of a response oriented chemotherapeutic
regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive nonHodgkin's lymphoma. Leuk Lymphoma 1999; 34(3-4): 361–71.
43.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A. Variations of nucleotide
sequences and transcription of the SH gene among mumps virus strains. Virology 1991; 18: 364–6.
44.
L'Huillier AG, Eshaghi A, Racey CS, et al. Laboratory testing and phylogenetic analysis during
a mumps outbreak in Ontario, Canada. Virol J 2018; 15(1): 98.
45.
Cui A, Rivailler P, Zhu Z, et al. Evolutionary analysis of mumps viruses of genotype F collected
in mainland China in 2001-2015. Sci Rep 2017; 7(1): 17144.
46.
Choi WS, Choi JH, Choi JY, et al. Immunogenicity and Safety of a Live Attenuated Zoster
Vaccine (ZOSTAVAX™) in Korean Adults. J Korean Med Sci 2016; 31(1): 13–7.
47.
Bodewes R, Reijnen L, Kerkhof J, et al. Molecular epidemiology of mumps viruses in the
Netherlands, 2017-2019. PLoS One 2020; 15(9): e0233143.
39
38.
Hassan J, Kelly J, De Gascun C. Presence of low mumps-specific IgG in oral fluids is
associated with high mumps viral loads. J Clin Virol 2020; 129: 104517.
39.
Okafuji T, Yoshida N, Fujino M, et al. Rapid diagnostic method for detection of mumps virus
genome by loop-mediated isothermal amplification. J Clin Microbiol 2005; 43(4): 1625–31.
40.
Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and
its complications in Germany, 2005-2009. J Infect 2015; 70(2): 178–86.
41.
World Health Organization. Mumps virus vaccines: WHO position paper, March 2024.
Weekly Epidemiological Record 2024; 99(11): 115–33.
42.
Tarumi T, Sawada K, Koizumi K, et al. A pilot study of a response oriented chemotherapeutic
regimen combined with autologous peripheral blood progenitor cell transplantation in aggressive nonHodgkin's lymphoma. Leuk Lymphoma 1999; 34(3-4): 361–71.
43.
Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A, Sugiura A. Variations of nucleotide
sequences and transcription of the SH gene among mumps virus strains. Virology 1991; 18: 364–6.
44.
L'Huillier AG, Eshaghi A, Racey CS, et al. Laboratory testing and phylogenetic analysis during
a mumps outbreak in Ontario, Canada. Virol J 2018; 15(1): 98.
45.
Cui A, Rivailler P, Zhu Z, et al. Evolutionary analysis of mumps viruses of genotype F collected
in mainland China in 2001-2015. Sci Rep 2017; 7(1): 17144.
46.
Choi WS, Choi JH, Choi JY, et al. Immunogenicity and Safety of a Live Attenuated Zoster
Vaccine (ZOSTAVAX™) in Korean Adults. J Korean Med Sci 2016; 31(1): 13–7.
47.
Bodewes R, Reijnen L, Kerkhof J, et al. Molecular epidemiology of mumps viruses in the
Netherlands, 2017-2019. PLoS One 2020; 15(9): e0233143.
39